ATE315403T1 - Multivalenter human-boviner rotavirus-impfstoff - Google Patents

Multivalenter human-boviner rotavirus-impfstoff

Info

Publication number: ATE315403T1
Authority: AT; Austria
Prior art keywords: human; producing; rotavirus vaccine; bovine rotavirus; multivalent
Prior art date: 1998-07-28

Application number

AT99938819T

Other languages

English (en)

Inventor

Albert Z Kapikian

Robert M Chanock

Yasutaka Hoshino

Original Assignee

Us Gov Health & Human Serv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-28

Filing date

1999-07-27

Publication date

2006-02-15

1999-07-27 Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv

2006-02-15 Application granted granted Critical

2006-02-15 Publication of ATE315403T1 publication Critical patent/ATE315403T1/de

Links

229940124859 Rotavirus vaccine Drugs 0.000 title 1
239000000203 mixture Substances 0.000 abstract 2
230000001052 transient effect Effects 0.000 abstract 2
241000283690 Bos taurus Species 0.000 abstract 1
241000617996 Human rotavirus Species 0.000 abstract 1
241000702670 Rotavirus Species 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
230000009851 immunogenic response Effects 0.000 abstract 1
230000005847 immunogenicity Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)

AT99938819T 1998-07-28 1999-07-27 Multivalenter human-boviner rotavirus-impfstoff ATE315403T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US9442598P	1998-07-28	1998-07-28

Publications (1)

Publication Number	Publication Date
ATE315403T1 true ATE315403T1 (de)	2006-02-15

Family

ID=22245113

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99938819T ATE315403T1 (de)	1998-07-28	1999-07-27	Multivalenter human-boviner rotavirus-impfstoff

Country Status (11)

Country	Link
US (1)	US7932074B1 (de)
EP (1)	EP1100537B1 (de)
JP (2)	JP4414095B2 (de)
KR (1)	KR100688434B1 (de)
CN (2)	CN101318016B (de)
AT (1)	ATE315403T1 (de)
AU (1)	AU759123B2 (de)
BR (1)	BRPI9912485B8 (de)
CA (1)	CA2336875C (de)
DE (1)	DE69929443T2 (de)
WO (1)	WO2000006196A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI9912485B8 (pt) *	1998-07-28	2021-05-25	The Government Of The Us Secretary Department Of Health And Human Services	composição imunogênica multivalente
US8168202B2 (en)	2005-07-07	2012-05-01	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Hexavalent bovine rotavirus reassortant composition designed for use in developing countries
WO2007008905A1 (en) *	2005-07-11	2007-01-18	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Porcine rotavirus reassortant compositions
CN102695522B (zh)	2009-05-12	2016-10-19	美国政府(由卫生和人类服务部、疾病控制和预防中心的部长所代表)	新的人轮状病毒株和疫苗
EP2646051A4 (de)	2010-12-02	2014-05-28	Oncolytics Biotech Inc	Flüssige virale formulierungen
MX349294B (es)	2010-12-02	2017-07-21	Oncolytics Biotech Inc	Formulaciones virales liofilizadas.
MA44557B1 (fr)	2016-06-16	2021-11-30	Bharat Biotech Int Ltd	Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer
JP2022521217A (ja) *	2019-02-19	2022-04-06	メディカゴインコーポレイテッド	ロタウイルスｖｐ７融合タンパク質およびそれらを含むロタウイルス様粒子
CN110903403B (zh) *	2019-12-16	2021-07-13	中国农业大学	一种牛轮状病毒嵌合抗原以及检测牛轮状病毒抗体的胶体金免疫层析试纸卡
CN113994925B (zh) *	2021-12-30	2022-04-26	北京赛尔富森生物科技有限公司	一种轮状病毒攻毒动物模型及其建立方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4571385A (en)	1983-06-27	1986-02-18	The United States Of America As Represented By The Department Of Health And Human Services	Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
EP0235391B1 (de) *	1985-12-26	1992-06-10	The University of Saskatchewan	Den antigenischen und immunogenischen Determinanten von wichtigen neutralisierenden Proteinen des Rotavirus entsprechende Peptide
US5626851A (en) *	1987-11-30	1997-05-06	The Wistar Institute Of Anatomy And Biology	Rotavirus reassortant vaccine
BRPI9912485B8 (pt) *	1998-07-28	2021-05-25	The Government Of The Us Secretary Department Of Health And Human Services	composição imunogênica multivalente

1999
- 1999-07-27 BR BRPI9912485A patent/BRPI9912485B8/pt not_active IP Right Cessation
- 1999-07-27 AU AU53221/99A patent/AU759123B2/en not_active Expired
- 1999-07-27 CN CN2008100903972A patent/CN101318016B/zh not_active Expired - Lifetime
- 1999-07-27 DE DE1999629443 patent/DE69929443T2/de not_active Expired - Lifetime
- 1999-07-27 CN CNB99810311XA patent/CN100387300C/zh not_active Expired - Lifetime
- 1999-07-27 JP JP2000562050A patent/JP4414095B2/ja not_active Expired - Lifetime
- 1999-07-27 KR KR1020017001236A patent/KR100688434B1/ko not_active Expired - Lifetime
- 1999-07-27 CA CA 2336875 patent/CA2336875C/en not_active Expired - Lifetime
- 1999-07-27 WO PCT/US1999/017036 patent/WO2000006196A2/en not_active Ceased
- 1999-07-27 AT AT99938819T patent/ATE315403T1/de not_active IP Right Cessation
- 1999-07-27 EP EP19990938819 patent/EP1100537B1/de not_active Expired - Lifetime
- 1999-07-27 US US09/743,338 patent/US7932074B1/en not_active Expired - Fee Related
2009
- 2009-06-23 JP JP2009148918A patent/JP2009209161A/ja active Pending

Also Published As

Publication number	Publication date
CN1315872A (zh)	2001-10-03
EP1100537B1 (de)	2006-01-11
AU759123B2 (en)	2003-04-03
DE69929443D1 (de)	2006-04-06
CN101318016B (zh)	2013-06-19
KR20010072096A (ko)	2001-07-31
EP1100537A2 (de)	2001-05-23
WO2000006196A3 (en)	2000-06-15
CA2336875A1 (en)	2000-02-10
BRPI9912485B1 (pt)	2018-09-18
JP2002521459A (ja)	2002-07-16
CN100387300C (zh)	2008-05-14
CN101318016A (zh)	2008-12-10
JP4414095B2 (ja)	2010-02-10
CA2336875C (en)	2014-01-07
WO2000006196A2 (en)	2000-02-10
KR100688434B1 (ko)	2007-03-09
JP2009209161A (ja)	2009-09-17
AU5322199A (en)	2000-02-21
US7932074B1 (en)	2011-04-26
BRPI9912485B8 (pt)	2021-05-25
BR9912485A (pt)	2001-04-17
DE69929443T2 (de)	2006-07-27

Legal Events

Date	Code	Title	Description
2006-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
NO20015073L (no)	2001-11-22	Vaksiner
BRPI9710460B8 (pt)	2021-05-25	composição imunogênica multi-valente e composição de vacina
ATE315403T1 (de)	2006-02-15	Multivalenter human-boviner rotavirus-impfstoff
WO2002028422A3 (en)	2002-08-29	Split enveloped virus preparation for intranasal delivery
UY26801A1 (es)	2002-01-31	Composición de vacuna
PT1154790E (pt)	2005-03-31	Reforco da actividade bactericida de antigenios contra a neisseria com oligonucleotidos contendo motivos cg
NZ596870A (en)	2013-06-28	Vaccine compositions comprising a saponin adjuvant
GB0025577D0 (en)	2000-12-06	Vaccine
EP2275122A3 (de)	2011-05-18	Streptococcus-pneumoniae-Vakzine auf Proteinbasis
WO2001097841A3 (en)	2002-05-30	Qs-21 and il-12 as an adjuvant combination
CA2266486A1 (en)	1998-04-02	Rotavirus vaccine formulations
LU91251I2 (fr)	2006-08-14	Vaccin à rotavirus (vivant) et ses dérivés pharmaceutiquement acceptables (ROTARIXr)
AR011919A1 (es)	2000-09-13	FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
PT1015595E (pt)	2005-05-31	Peptidos derivados da proteina de ligacao (g) do virus sincicial respiratorio
GR3024173T3 (en)	1997-10-31	Assembled viral particles and their use in a vaccine to rotaviral disease.
AU5577201A (en)	2001-11-07	Immunogenic pneumococcal protein and vaccine compositions thereof
WO2007009081A3 (en)	2007-07-12	A hexavalent bovine rotavirus reassortant composition designed for use in developing countries
WO2004006851A3 (en)	2004-03-18	Mycoplasma gallisepticum formulation
EP1905449A3 (de)	2009-03-25	Adjuvants zusammensetzung enthaltend saponin und ein immunstimulierendes oligonukliotid
WO2002036160A3 (es)	2003-05-30	Método de obtención de estructuras antigénicas que potencian la reactividad cruzada específica
DE3854575D1 (de)	1995-11-16	Reassortantes Rotavirusvakzin.
ATE462446T1 (de)	2010-04-15	Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen
ATE437651T1 (de)	2009-08-15	Parenterale impfstoff-formulierungen und deren verwendung
AP2004003081A0 (en)	2004-09-30	Immunogenic formulations of variable peptidic epitopes and for preparation thereof
WO2000051633A3 (en)	2001-01-25	MULTI-COMPONENT VACCINE COMPRISING AT LEAST THREE ANTIGENS TO PROTECT AGAINST DISEASE CAUSED BY $i(HAEMOPHILUS INFLUENZAE)